en

PRODUCT DETAIL

Seretide 250 Inhaler N

Code 13428
MA number 14/0115/01-S
Product Form: sus inh 1x120 dávok (nád.tlak.Al)
MA Status: D - Marketing Authorisation valid for an unlimited period
Type of procedure: National
Therapeutic Class: 14 - BRONCHODILATANTIA, ANTIASTHMATICA
ATC:
R RESPIRATORY SYSTEM
R03 DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
R03A ADRENERGICS, INHALANTS
R03AK Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics
R03AK06 Salmeterol and fluticasone
Shelf life: 24
Container: pressurised container, aluminium
Route of admin.: Inhalation use
Prescription Status: Medicinal product subject to medical prescription.
Legal basis: Article 8(3) application - new active substance
MA issued: 04.04.2001
Pediatric indication: Yes
Pediatric posology: Yes
Pediatric warnings: Yes
SPC: SPC_Seretide Inhaler N_50, 125, 250 mcg_08.2022.pdf  
PIL: PIL_Seretide Inhaler N_50, 125, 250 mcg_08.2022.pdf  
Safety feature Yes
Data update: 05.06.2018
eu-flag.png sk-flag.png